Nuvation Bio Inc (NYSE:NUVB) shares, rose in value on Thursday, March 27, with the stock price down by -0.53% to the previous day’s close as strong demand from buyers drove the stock to $1.87.
Actively observing the price movement in the last trading, the stock closed the session at $1.88, falling within a range of $1.85 and $1.905. The value of beta (5-year monthly) was 1.472. Referring to stock’s 52-week performance, its high was $4.16, and the low was $1.71. On the whole, NUVB has fluctuated by -5.56% over the past month.
With the market capitalization of Nuvation Bio Inc currently standing at about $633.33 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-05.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 416.67k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that NUVB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of NUVB currently trading nearly -5.75% and -15.29% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.28, while the 7-day volatility ratio is showing 5.35% which for the 30-day chart, stands at 9.16%. Furthermore, Nuvation Bio Inc (NUVB)’s beta value is 1.45, and its average true range (ATR) is 0.15.
A comparison of Nuvation Bio Inc (NUVB) with its peers suggests the former has fared considerably weaker in the market. NUVB showed an intraday change of -0.53% in last session, and over the past year, it shrunk by -16.89%%.
Data on historical trading for Nuvation Bio Inc (NYSE:NUVB) indicates that the trading volumes over the past 10 days have averaged 2.32 and over the past 3 months, they’ve averaged 2.56 million. According to company’s latest data on outstanding shares, there are 336.84 million shares outstanding.
Nearly 33.03% of Nuvation Bio Inc’s shares belong to company insiders and institutional investors own 45.77% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 28.39 million shares as on 2025-03-14, resulting in a short ratio of 9.84. According to the data, the short interest in Nuvation Bio Inc (NUVB) stood at 1173.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 26.17 million. The stock has fallen by -29.70% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NUVB stock heading into the next quarter.
